These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
99-0370688
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
x
|
|
(Do not check if a smaller reporting company)
|
|
Financial Statements-
|
||||
|
Balance Sheets as of March 31, 2013 and December 31, 2012
|
F-2 | |||
|
Statements of Operations for the Three Months Ended March 31, 2013 and 2012, and Cumulative from Inception
|
F-3 | |||
|
Statement of Stockholders’ Equity for the Period from Inception
through March 31, 2013
|
F-4 | |||
|
Statements of Cash Flows for the Three Months Ended March 31, 2013 and 2012, and Cumulative from Inception
|
F-5 | |||
|
Notes to Financial Statements
|
F-6 | |||
|
As of
|
As of
|
|||||||
|
March 31,
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
|
Current Assets:
|
||||||||
|
Cash or cash equivalents
|
$ | 458 | $ | 577 | ||||
|
Total current assets
|
458 | 577 | ||||||
|
Total Assets
|
$ | 458 | $ | 577 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 14,750 | $ | 11,655 | ||||
|
Due to shareholders
|
238 | 238 | ||||||
|
Total Current Liabilities
|
14,988 | 11,893 | ||||||
|
Commitments and Contingencies
|
- | - | ||||||
|
Stockholders' Equity (Deficit):
|
||||||||
|
Common stock, par value $0.0001 per share, 100,000,000 shares authorized;
|
||||||||
|
3,500,000 shares issued and outstanding
|
350 | 350 | ||||||
|
Additional paid-in capital
|
70,150 | 70,150 | ||||||
|
(Deficit) accumulated during development stage
|
(85,029 | ) | (81,816 | ) | ||||
|
Total stockholders' equity (deficit)
|
(14,529 | ) | (11,316 | ) | ||||
|
Total Liabilities and Stockholders' Equity
|
$ | 458 | $ | 577 | ||||
|
Three Months
|
Three Months
|
|||||||||||
|
Ended
|
Ended
|
Cumulative
|
||||||||||
|
March, 31
|
March, 31
|
From
|
||||||||||
|
2013
|
2012
|
Inception
|
||||||||||
|
Revenues
|
$ | - | $ | - | $ | - | ||||||
|
Expenses:
|
||||||||||||
|
General and administrative -
|
||||||||||||
|
Filing fee
|
795 | 2,227 | 8,144 | |||||||||
|
Professional fees
|
2,389 | 2,154 | 40,919 | |||||||||
|
Consulting fees
|
- | - | 33,975 | |||||||||
|
Incorporation
|
- | - | 867 | |||||||||
|
Franchise tax expense
|
- | 400 | 400 | |||||||||
|
Other
|
30 | 31 | 725 | |||||||||
|
Total general and administrative expenses
|
3,214 | 4,812 | 85,029 | |||||||||
| - | - | - | ||||||||||
|
(Loss) from Operations
|
(3,214 | ) | (4,812 | ) | (85,029 | ) | ||||||
|
Provision for income taxes
|
- | - | - | |||||||||
|
Net (Loss)
|
$ | (3,214 | ) | $ | (4,812 | ) | $ | (85,029 | ) | |||
|
(Loss) Per Common Share:
|
||||||||||||
|
(Loss) per common share - Basic and Diluted
|
$ | (0.00 | ) | $ | (0.00 | ) | ||||||
|
Weighted Average Number of Common Shares
|
||||||||||||
|
Outstanding - Basic and Diluted
|
3,500,000 | 3,000,000 | ||||||||||
|
|
Common stock
|
Additional
Paid-in
|
(Deficit) Accumulated
During the
Development
|
|
||||||||||||||||
|
Description
|
Shares
|
Amount
|
Capital | Stage |
Totals
|
|||||||||||||||
|
Balance - at inception
|
- | $ | - | $ | - | $ | - | $ | - | |||||||||||
|
Common stock issued for cash ($0.01/share)
|
3,000,000 | 300 | 29,700 | - | 30,000 | |||||||||||||||
|
Net (loss) for the period
|
- | - | - | (5,162 | ) | (5,162 | ) | |||||||||||||
|
Balance - December 31, 2011
|
3,000,000 | 300 | 29,700 | (5,162 | ) | 24,838 | ||||||||||||||
|
Common stock issued for cash ($0.1/share)
|
500,000 | 50 | 40,450 | - | 40,500 | |||||||||||||||
|
Net (loss) for the period
|
- | - | - | (76,654 | ) | (76,654 | ) | |||||||||||||
|
Balance - December 31, 2012
|
3,500,000 | $ | 350 | $ | 70,150 | $ | (81,816 | ) | $ | (11,316 | ) | |||||||||
|
Net (loss) for the period
|
- | - | - | (3,214 | ) | (3,214 | ) | |||||||||||||
|
Balance - March 31, 2013
|
3,500,000 | $ | 350 | $ | 70,150 | $ | (85,029 | ) | $ | (14,529 | ) | |||||||||
|
Three Months
Ended
March 31,
|
Three Months
Ended
March 31,
|
Cumulative
From
|
||||||||||
|
2013
|
2012
|
Inception
|
||||||||||
|
Operating Activities :
|
||||||||||||
|
Net (loss)
|
$ | (3,214 | ) | $ | (4,812 | ) | $ | (85,029 | ) | |||
|
Adjustments to reconcile net (loss) to net cash
provided by operating activities:
|
||||||||||||
|
Accounts payable and accrued liabilities
|
3,095 | (240 | ) | 14,750 | ||||||||
|
Net Cash Used in Operating Activities
|
(119 | ) | (5,052 | ) | (70,280 | ) | ||||||
|
Investing Activities :
|
||||||||||||
|
Cash provided by investing activities
|
- | - | - | |||||||||
|
Net Cash Provided by Investing Activities
|
- | - | - | |||||||||
|
Financing Activities :
|
||||||||||||
|
Due to shareholders
|
- | - | 238 | |||||||||
|
Proceeds from common stock
|
- | - | 70,500 | |||||||||
|
Net Cash Provided by Financing Activities
|
- | - | 70,738 | |||||||||
|
Net (Decrease) Increase in Cash
|
(119 | ) | (5,052 | ) | 458 | |||||||
|
Cash - Beginning of Period
|
577 | 22,943 | - | |||||||||
|
Cash - End of Period
|
$ | 458 | $ | 17,891 | $ | 458 | ||||||
|
Supplemental Disclosure of Cash Flow Information:
|
||||||||||||
|
Cash paid during the period for:
|
||||||||||||
|
Interest
|
$ | - | $ | - | $ | - | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
2013
|
2012
|
|||||||
|
Current Tax Provision:
|
||||||||
|
Federal-
|
||||||||
|
Taxable income
|
$ | - | $ | - | ||||
|
Total current tax provision
|
$ | - | $ | - | ||||
|
Deferred Tax Provision:
|
||||||||
|
Federal-
|
||||||||
|
Loss carryforwards
|
$ | 482 | $ | 722 | ||||
|
Change in valuation allowance
|
(482 | ) | (722 | ) | ||||
|
Total deferred tax provision
|
$ | - | $ | - | ||||
|
2013
|
2012
|
|||||||
|
Loss carryforwards
|
$ | 12,754 | $ | 12,272 | ||||
|
Less - Valuation allowance
|
(12,754 | ) | (12,272 | ) | ||||
|
Total net deferred tax assets
|
$ | - | $ | - | ||||
|
Exhibit No.
|
Description
|
|
|
3.1
|
Articles of Incorporation (Incorporated by reference from our Registration Statement on Form S-1).
|
|
|
3.2
|
Bylaws (Incorporated by reference from our Registration Statement on Form S-1).
|
|
|
31*
|
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Israel Menahem Vizel.
|
|
|
32*
|
Section 906 Certification of the Sarbanes-Oxley Act of 2002 of Israel Menahem Vizel.
|
|
101.INS **
|
XBRL Instance Document
|
|
|
101.SCH **
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL **
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF **
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB **
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE **
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
/s/
Israel Menahem Vizel
|
|
|
President, Chief Executive Officer, Chief Financial Officer and a member of the Board of Directors
(who also performs as the Principal Executive and Principal Financial and Accounting Officer)
April 24, 2013
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|